The population was enriched with a sicker phenotype than prior trials, which may have enhanced the impact on hard outcomes.
The study showed notable sex-based differences, as well as a trend toward better survival in those who got an intervention.
SAN DIEGO, CA—Patients treated with the Agent drug-coated balloon (DCB; Boston Scientific) have encouraging outcomes at 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results